{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:37:09Z","timestamp":1793277429081,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["2025230001000251"],"award-info":[{"award-number":["2025230001000251"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114716","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:24:57Z","timestamp":1770769497000},"page":"114716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Augmenting cuproptosis and anti-metastatic immunity in breast cancer by copper-based nanoplatform for synergistic immunotherapy via lactate metabolic reprogramming and hypoxia alleviation"],"prefix":"10.1016","volume":"392","author":[{"given":"Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keru","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunbin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40364-024-00631-8","article-title":"Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the global burden of disease study 2021","volume":"12","author":"Sha","year":"2024","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114716_bb0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41416-022-01845-z","article-title":"Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study","volume":"127","author":"Valachis","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.jconrel.2026.114716_bb0020","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib keynote-012 study","volume":"34","author":"Nanda","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114716_bb0025","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jnci\/djab004","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer: biomarker evaluation of the IMpassion130 study","volume":"113","author":"Emens","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03394-8","article-title":"Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy","volume":"44","author":"Imani","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6586","key":"10.1016\/j.jconrel.2026.114716_bb0035","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.jconrel.2026.114716_bb0045","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.3c07775","article-title":"Cuproptosis: harnessing transition metal for cancer therapy","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.jconrel.2026.114716_bb0050","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1039\/D5CS00083A","article-title":"Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond","volume":"54","author":"Mao","year":"2025","journal-title":"Chem. Soc. Rev."},{"issue":"51","key":"10.1016\/j.jconrel.2026.114716_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202306584","article-title":"Clinical chemotherapeutic agent coordinated copper-based nanoadjuvants for efficiently sensitizing cancer chemo-immunotherapy by cuproptosis-mediated mitochondrial metabolic reprogramming","volume":"33","author":"Tian","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114716_bb0060","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","article-title":"Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives","volume":"43","author":"Fang","year":"2023","journal-title":"Cancer Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114716_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114716_bb0075","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41582-020-0391-x","article-title":"Management of brain metastases according to molecular subtypes","volume":"16","author":"Soffietti","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114716_bb0085","first-page":"73","article-title":"A dual-targeting strategy to inhibit colorectal cancer liver metastasis via tumor cell ferroptosis and cancer-associated fibroblast reprogramming","volume":"52","author":"Wu","year":"2025","journal-title":"Bioact. Mater."},{"issue":"38","key":"10.1016\/j.jconrel.2026.114716_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403473","article-title":"Nanomaterials that aid in the diagnosis and treatment of Alzheimer\u2019s disease, resolving blood-brain barrier crossing ability","volume":"11","author":"Song","year":"2024","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114716_bb0095","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1021\/acsami.6b15831","article-title":"Peptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB","volume":"9","author":"Chen","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114716_bb0100","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.3390\/ijms23169361","article-title":"Lipid nanoparticles: promising treatment approach for Parkinson\u2019s disease","volume":"23","author":"Jagaran","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114716_bb0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcis.2022.07.025","article-title":"Transport of cationic liposomes in a human blood brain barrier model: role of the stereochemistry of the gemini amphiphile on liposome biological features","volume":"627","author":"Simonis","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.114716_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114075","article-title":"Augmenting cGAS\/STING-mediated innate immunity by copper-based nanoplatform for synergistic cancer immunotherapy via inducing irreversible DNA damage","volume":"386","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114716_bb0115","article-title":"Engineered microbial nanohybrids for tumor-mediated NIR II photothermal enhanced ferroptosis\/cuproptosis and immunotherapy","volume":"13","author":"Ruan","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114716_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308033","article-title":"\u201cThree-in-one\u201d nanozyme composite for augmented cascade catalytic tumor therapy","volume":"36","author":"Cheng","year":"2024","journal-title":"Adv. Mater."},{"issue":"43","key":"10.1016\/j.jconrel.2026.114716_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004647","article-title":"Colorectal tumor microenvironment-activated bio-decomposable and metabolizable cu 2 O@CaCO 3 nanocomposites for synergistic oncotherapy","volume":"32","author":"Chang","year":"2020","journal-title":"Adv. Mater."},{"issue":"52","key":"10.1016\/j.jconrel.2026.114716_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202411247","article-title":"Boosting ferroptosis and immunotherapy for colorectal cancer by lactate-related metabolic reprogramming","volume":"34","author":"Li","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25561-z","article-title":"Peroxisome inspired hybrid enzyme nanogels for chemodynamic and photodynamic therapy","volume":"12","author":"Qin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114716_bb0140","first-page":"2188","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype, Immunity (Cambridge MA.)","volume":"56","author":"Mellman","year":"2023"},{"issue":"43","key":"10.1016\/j.jconrel.2026.114716_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202302758","article-title":"Cancer immunotherapy based on cell membrane-coated nanocomposites augmenting cGAS\/STING activation by efferocytosis blockade","volume":"19","author":"Chen","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114716_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114932","article-title":"Apoptosis and mitochondrial DNA damaged induced by Zn2+ \/Ca2+ dual-ions overload for colorectal cancer improved immunotherapy","volume":"255","author":"Wang","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.114716_bb0155","article-title":"Multifunctional liposome boosts glioma ferroptosis and immunotherapy through reinforcement of chemo-dynamic therapy strategy","volume":"31","author":"Chen","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114716_bb0160","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","article-title":"Immune-mediated inflammatory disease therapeutics: past, present and future","volume":"21","author":"Mcinnes","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0165","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114716_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207951","article-title":"Lactate-oxidase-instructed cancer diagnosis and therapy","volume":"35","author":"Jiang","year":"2023","journal-title":"Adv. Mater."},{"issue":"26","key":"10.1016\/j.jconrel.2026.114716_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300686","article-title":"Lactate efflux inhibition by Syrosingopine\/LOD co-loaded nanozyme for synergetic self-replenishing catalytic cancer therapy and immune microenvironment remodeling","volume":"10","author":"Wu","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12951-022-01762-6","article-title":"Lactate oxidase\/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth","volume":"21","author":"Choi","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114716_bb0185","first-page":"140868","article-title":"Cancer Cell Membrane Biomimetic Mesoporous Silica Nanotheranostics for Enhanced Ferroptosis-mediated Immuogenic Cell Death on Gastric","volume":"455","author":"Guo","year":"1996","journal-title":"Cancer,Chem. Eng. J., (Lausanne, Switzerland)"},{"key":"10.1016\/j.jconrel.2026.114716_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122512","article-title":"Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA-cGAS-STING signaling","volume":"307","author":"Yu","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114716_bb0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mattod.2023.06.024","article-title":"Orchestrated copper-based nanoreactor for remodeling tumor microenvironment to amplify cuproptosis-mediated anti-tumor immunity in colorectal cancer","volume":"68","author":"Jin","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.114716_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214228","article-title":"Precision targeted melanoma therapy via cuproptosis\/chemodynamic and chemotherapy: an engineering MCHS-CuMOF nanodelivery system","volume":"171","author":"Zhang","year":"2025","journal-title":"Biomater. Adv."},{"issue":"22","key":"10.1016\/j.jconrel.2026.114716_bb0210","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114716_bb0220","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"18","key":"10.1016\/j.jconrel.2026.114716_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309984","article-title":"Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114716_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404612","article-title":"Inducing cuproptosis with copper ion-loaded aloe emodin self-assembled nanoparticles for enhanced tumor photodynamic immunotherapy","volume":"14","author":"Yu","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"30","key":"10.1016\/j.jconrel.2026.114716_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202405639","article-title":"Sono-triggered cascade lactate depletion by semiconducting polymer nanoreactors for cuproptosis-immunotherapy of pancreatic cancer","volume":"63","author":"Yu","year":"2024","journal-title":"Angew. Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114716_bb0240","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114716_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103209","article-title":"Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression","volume":"74","author":"Gu","year":"2024","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114716_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110792","article-title":"The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62","volume":"39","author":"Linares","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0255","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114716_bb0260","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114716_bb0265","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01358-5","article-title":"Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications","volume":"15","author":"Zhong","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114716_bb0270","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114716_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216837","article-title":"The emerging role of lactate in tumor microenvironment and its clinical relevance","volume":"590","author":"Chen","year":"2024","journal-title":"Cancer Lett."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:32:31Z","timestamp":1787128351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926001185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"alternative-id":["S0168365926001185"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114716","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmenting cuproptosis and anti-metastatic immunity in breast cancer by copper-based nanoplatform for synergistic immunotherapy via lactate metabolic reprogramming and hypoxia alleviation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114716"}}